Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma
Ann Hematol
.
2012 Jan;91(1):129-30.
doi: 10.1007/s00277-011-1216-1.
Epub 2011 Mar 25.
Authors
Sonja Reitter
,
Angelika Rohn
,
Helmut H Schmidt
,
Werner Linkesch
PMID:
21437587
DOI:
10.1007/s00277-011-1216-1
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Aged, 80 and over
Female
Humans
Lymphoma, B-Cell / immunology*
Lymphoma, B-Cell / pathology
Lymphoma, B-Cell / radiotherapy*
Radioimmunotherapy / methods*
Treatment Outcome